Safety and Reactogenicity of the ChAdOx1 (AZD1222) COVID-19 Vaccine in Saudi Arabia

INTRODUCTION: The Kingdom of Saudi Arabia was one of the first countries to implement a COVID-19 vaccination program. This study estimated the safety and reactogenicity of the ChAdOx1-S vaccine after the first dose administered to adults. METHODS: This cross-sectional study included 1592 randomly se...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Bahrani, Salma, Albarrak, Ali, Alghamdi, Othman Ali, Alghamdi, Mesfer Abdullah, Hakami, Fatimah H., Al Abaadi, Asmaa K., Alkhrashi, Sausan A., Alghamdi, Mansour Y., Almershad, Meshael M., Alenazi, Mansour Moklif, El Gezery, Mohamed Hany, Jebakumar, Arulanantham Zechariah, Al-Tawfiq, Jaffar A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310569/
https://www.ncbi.nlm.nih.gov/pubmed/34320413
http://dx.doi.org/10.1016/j.ijid.2021.07.052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310569/
https://www.ncbi.nlm.nih.gov/pubmed/34320413
http://dx.doi.org/10.1016/j.ijid.2021.07.052

Ejemplares similares